149 related articles for article (PubMed ID: 31523031)
1. New advances in targeting aberrant signaling pathways in T-cell acute lymphoblastic leukemia.
Paganelli F; Lonetti A; Anselmi L; Martelli AM; Evangelisti C; Chiarini F
Adv Biol Regul; 2019 Dec; 74():100649. PubMed ID: 31523031
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.
Bongiovanni D; Saccomani V; Piovan E
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28872614
[TBL] [Abstract][Full Text] [Related]
3. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
[TBL] [Abstract][Full Text] [Related]
4. The genetics and mechanisms of T cell acute lymphoblastic leukaemia.
Belver L; Ferrando A
Nat Rev Cancer; 2016 Jul; 16(8):494-507. PubMed ID: 27451956
[TBL] [Abstract][Full Text] [Related]
5. ZEB2 in T-cells and T-ALL.
De Coninck S; Berx G; Taghon T; Van Vlierberghe P; Goossens S
Adv Biol Regul; 2019 Dec; 74():100639. PubMed ID: 31383581
[TBL] [Abstract][Full Text] [Related]
6. Ezh2 loss propagates hypermethylation at T cell differentiation-regulating genes to promote leukemic transformation.
Wang C; Oshima M; Sato D; Matsui H; Kubota S; Aoyama K; Nakajima-Takagi Y; Koide S; Matsubayashi J; Mochizuki-Kashio M; Nakano-Yokomizo T; Bai J; Nagao T; Kanai A; Iwama A; Sashida G
J Clin Invest; 2018 Aug; 128(9):3872-3886. PubMed ID: 30080177
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of acute lymphoblastic leukemia.
Teitell MA; Pandolfi PP
Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
[TBL] [Abstract][Full Text] [Related]
8. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor (IGF) signaling in T-cell acute lymphoblastic leukemia.
Gusscott S; Tamiro F; Giambra V; Weng AP
Adv Biol Regul; 2019 Dec; 74():100652. PubMed ID: 31543360
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically heterogeneous mouse model of T-cell acute lymphoblastic leukemia.
Gao J; Van Meter M; Hernandez Lopez S; Chen G; Huang Y; Ren S; Zhao Q; Rojas J; Gurer C; Thurston G; Kuhnert F
Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399482
[TBL] [Abstract][Full Text] [Related]
11. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
12. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of T cell acute lymphoblastic leukemia.
Van Vlierberghe P; Ferrando A
J Clin Invest; 2012 Oct; 122(10):3398-406. PubMed ID: 23023710
[TBL] [Abstract][Full Text] [Related]
14. PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
Garcia EG; Veloso A; Oliveira ML; Allen JR; Loontiens S; Brunson D; Do D; Yan C; Morris R; Iyer S; Garcia SP; Iftimia N; Van Loocke W; Matthijssens F; McCarthy K; Barata JT; Speleman F; Taghon T; Gutierrez A; Van Vlierberghe P; Haas W; Blackburn JS; Langenau DM
Leukemia; 2021 Mar; 35(3):679-690. PubMed ID: 32606318
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Mechanisms of Drug Resistance in Leukemia.
Knoechel B; Aster JC
Cell Metab; 2015 Nov; 22(5):759-60. PubMed ID: 26536486
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in T-cell lymphoid neoplasms.
Bigas A; Rodriguez-Sevilla JJ; Espinosa L; Gallardo F
Exp Hematol; 2022 Feb; 106():3-18. PubMed ID: 34879258
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia.
Burns MA; Liao ZW; Yamagata N; Pouliot GP; Stevenson KE; Neuberg DS; Thorner AR; Ducar M; Silverman EA; Hunger SP; Loh ML; Winter SS; Dunsmore KP; Wood B; Devidas M; Harris MH; Silverman LB; Sallan SE; Gutierrez A
Leukemia; 2018 Oct; 32(10):2126-2137. PubMed ID: 29654263
[TBL] [Abstract][Full Text] [Related]
18. From the outside, from within: Biological and therapeutic relevance of signal transduction in T-cell acute lymphoblastic leukemia.
Oliveira ML; Akkapeddi P; Alcobia I; Almeida AR; Cardoso BA; Fragoso R; Serafim TL; Barata JT
Cell Signal; 2017 Oct; 38():10-25. PubMed ID: 28645565
[TBL] [Abstract][Full Text] [Related]
19. Notch in T-ALL: new players in a complex disease.
Koch U; Radtke F
Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
[TBL] [Abstract][Full Text] [Related]
20. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
